A COMPREHENSIVE DISCHARGE PLANNING PROGRAM ON FATIGUE AND FUNCTIONAL STATUS IN HEPATOCELLULAR CARCINOMA PATIENTS UNDERGOING TRANSARTERIAL CHEMOEMBOLIZATIO

Phase 1

Completed

• Conditions: Hepatocellular carcinoma patients undergoing transarterial chemoembolization; Discharge Planning, Transarterial Chemoembolization, Hepatocellular Carcinoma, Fatigue, Functional Status

• Registration Number: TCTR20220101002
• Lead Sponsor: Faculty of Nursing, Mahidol University

Brief Summary

52 participants (Experimental 26,Control 26) Male:36,Female:16. Ages most of them in range of 60-70. BCLC A:6,B:45,C:1,Child-Pung A:50,B:2. ECOG0:45,ECOG1:7. Fatigue levels (Mean+-S.D)Experimental Day0,1,3,7,14,30 : 2.22 +-1.29,2.37+-1.40,2.60+-1.22,2.21+-1.23,1.88+-1.04,1.2+-0.58 Control Day0,1,3,7,14,30 :2.50+-1.51,2.49+-1.44,2.63+-1.18,2.81+-1.36,2.27+-1.04, 1.77+-0.85. Functional status: Experimental Day7,14,30 : 12.31+-1.81,11.62+-1.68,11.35+-1.44 Control Day7,14,30 : 3.04+-4.25,13.04+-4.25,12.69+-4.19

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-08-30
• Study Start: 2022-01-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

1. Hepatocellular carcinoma patients undergoing transarterial chemoembolization first time or second time.
2. Patients can communicate in Thai and understand.
3. Patients above 60 years of age with a cognitive score from a casual Thai Mental State Examination score is greater than or equal to 23 points
4. Patients must be able to be reached by phone.

Exclusion Criteria

1. Patients have a history of diagnosis of all kinds of psychiatric disorders
2. Stage of disease BCLC level D
3. ECOG Score more than 2
4. Received Combined TACE and RFA treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatigue the day after treatment transarterial chemoembolization (TACE) day 0, 1, 3, 7, 14 and 30. The fatigue severity scale (FFS)

Secondary Outcome Measures

Name	Time	Method
Functional status the day after treatment transarterial chemoembolization (TACE) day 7, 14 and 30. Enforced Social Dependency Scale (ESDS)